Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer

被引：4

作者：

Buyse, M

Thirion, P

Carlson, RW

Burzykowski, T

Molenberghs, G

Piedbois, P

机构：

[1] Int Inst Drug Dev, B-1050 Brussels, Belgium

[2] Limburgs Univ Ctr, Diepenbeek, Belgium

[3] Hop Henri Mondor, Dept Oncol, F-94010 Creteil, France

[4] Stanford Univ, Med Ctr, Dept Med, Palo Alto, CA 94304 USA

[5] Inst Oncol, Warsaw, Poland

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 05期

关键词：

D O I：

10.1093/jnci/93.5.399

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：399 / 400

页数：2

共 5 条

[1]

Buyse M, 2000, DRUG INF J, V34, P387, DOI 10.1177/009286150003400207

[2] Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis [J].

Buyse, M ;

Thirion, P ;

Carlson, RW ;

Burzykowski, T ;

Molenberghs, G ;

Piedbois, P .

LANCET, 2000, 356 (9227) :373-378

[3] A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer [J].

Chen, TT ;

Chute, JP ;

Feigal, E ;

Johnson, BE ;

Simon, R .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (19) :1601-1607

[4]

Croockewit A, 2000, LANCET, V356, P1771, DOI 10.1016/S0140-6736(05)71965-6

[5] Response rates, survival, and chemotherapy trials [J].

Pazdur, R .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (19) :1552-1553

← 1 →